GALNT14 antibody (AA 101-200)
-
- Target See all GALNT14 Antibodies
- GALNT14 (UDP-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 14 (GalNAc-T14) (GALNT14))
-
Binding Specificity
- AA 101-200
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This GALNT14 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
- Cross-Reactivity
- Human
- Predicted Reactivity
- Mouse,Rat
- Purification
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human GALNT14
- Isotype
- IgG
- Top Product
- Discover our top product GALNT14 Primary Antibody
-
-
- Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Expiry Date
- 12 months
-
-
Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer." in: Biomedicine & pharmacotherapy, Vol. 84, pp. 1078-1087, (2016) (PubMed).
: "
-
Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer." in: Biomedicine & pharmacotherapy, Vol. 84, pp. 1078-1087, (2016) (PubMed).
-
- Target
- GALNT14 (UDP-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 14 (GalNAc-T14) (GALNT14))
- Alternative Name
- GALNT14 (GALNT14 Products)
- Synonyms
- 0610033M06Rik antibody, si:ch211-147c1.1 antibody, GALNT15 antibody, GalNac-T10 antibody, GalNac-T14 antibody, polypeptide N-acetylgalactosaminyltransferase 14 antibody, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) antibody, GALNT14 antibody, galnt14 antibody, Galnt14 antibody
- Background
-
Synonyms: GalNAc T14, GalNAc-T14, Galnt14, GALNT14, GalNac-T10, GALNT15, pp-GaNTase 14, GLT14_HUMAN, Polypeptide GalNAc transferase 14, Polypeptide N acetylgalactosaminyltransferase 14, Polypeptide N-acetylgalactosaminyltransferase 14, pp GaNTase 14, Protein UDP acetylgalactosaminyltransferase 14, Protein-UDP acetylgalactosaminyltransferase 14, UDP GalNAc:polypeptide N acetylgalactosaminyltransferase 14, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14.
Background: This gene encodes a Golgi protein which is a member of the polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-Ts) protein family. These enzymes catalyze the transfer of N-acetyl-D-galactosamine (GalNAc) to the hydroxyl groups on serines and threonines in target peptides. The encoded protein has been shown to transfer GalNAc to large proteins like mucins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].
-